IL4 and inflammatory bowel disease: Moreover, miR-340 directly targets the pro-inflammatory cytokines IL-4 [87] and IL-17A [88] in psoriasis mice model, where Th17 cells and the consequent IL-17A production are implicated in the pathogenesis of this autoimmune disease as in others such as IBD [89].